SBIR/STTR Research Award

Oligonucleotide Error Filtering for Gene Synthesis

Award identifier 1f5d238c5a97d627ac6e485a288da356772b58a091f895d4597e6041ec9d6808Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Genetic Assemblies, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Genetic Assemblies Inc. proposes the development of an error filter for the elimination of errors introduced during the synthesis of oligonucleotides and longer DNA fragments. This filter is a critical enabling technology for an Automatic Gene Synthesizer (AGS), a project now under development at Genetic Assemblies Inc. (GA). The goal of the AGS is to produce user-defined DNA fragments of up to 10,000 bp in length, in less than 24 hours and with essentially no introduced errors. The error filter will be integrated with the massively parallel, light-directed DNA synthesis technology of the existing Maskless Array Synthesizer (MAS) and a light-directed oligonucleotide release chemistry developed by GA founders at the University of Wisconsin-Madison, and licensed to GA. Specific aims for the project include: attachment of an error binding protein to a solid support, determination of binding capacity and optimal binding conditions of the error filter, and determination of the optimal error filtering methodology. The ability to produce error-free long DNA fragments will revolutionize the field of molecular biology. It will allow the production of custom designed DNA for uses in protein engineering, DNA vaccines, gene therapy, and other research related to improving human health. This ability will significantly reduce the scientific community's reliance on large collections of cloned DNA fragments now used in genetic research, since almost any DNA of known sequence could be synthesized on demand. This technology will greatly accelerate the pace of genetic research and lead to the development of new drugs, treatments for genetic diseases and advanced genetic technologies.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.